| Kirsten Jordan Thompson, RPT | |
|
1311 Augusta Rd, West Columbia, SC 29169-6320 | |
| (803) 926-7204 | |
| Not Available |
| Full Name | Kirsten Jordan Thompson |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 28 Years |
| Location | 1311 Augusta Rd, West Columbia, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356308241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 3101 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Sigurd Center For Ortho And Neuro Rehab | 0547277063 | 11 |
News Archive
The second annual Dance To Conquer Cancer, Disco Days & Boogie Nights, raising funds for the Princess Margaret Cancer Centre, will take place on March 3, 2013, and will feature fitness guru Richard Simmons and three-time Grammy Award winners, the Pointer Sisters!
Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.
Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.
Clinicians often face the challenge of trying to make sense of conflicting reports from parents, teachers, and children about a child's behavioral problems. However, a better understanding of the source and nature of these disagreements may provide important information that could improve treatment and outcomes. A group of articles in the current issue of Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal published by Mary Ann Liebert, Inc., explores this challenging clinical dilemma.
Pfizer Inc. announced today that the European Commission has approved expanding the use of the company's pneumococcal conjugate vaccine, Prevenar 13(pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), to older children and adolescents aged 6 to 17 years for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumoniae.
› Verified 1 days ago
| Provider Name | The Sigurd Center For Ortho & Neuro Rehab |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376658542 PECOS PAC ID: 0547277063 Enrollment ID: O20060308000515 |
News Archive
The second annual Dance To Conquer Cancer, Disco Days & Boogie Nights, raising funds for the Princess Margaret Cancer Centre, will take place on March 3, 2013, and will feature fitness guru Richard Simmons and three-time Grammy Award winners, the Pointer Sisters!
Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.
Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.
Clinicians often face the challenge of trying to make sense of conflicting reports from parents, teachers, and children about a child's behavioral problems. However, a better understanding of the source and nature of these disagreements may provide important information that could improve treatment and outcomes. A group of articles in the current issue of Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal published by Mary Ann Liebert, Inc., explores this challenging clinical dilemma.
Pfizer Inc. announced today that the European Commission has approved expanding the use of the company's pneumococcal conjugate vaccine, Prevenar 13(pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), to older children and adolescents aged 6 to 17 years for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumoniae.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kirsten Jordan Thompson, RPT 1311 Augusta Rd, West Columbia, SC 29169-6320 Ph: (803) 926-7204 | Kirsten Jordan Thompson, RPT 1311 Augusta Rd, West Columbia, SC 29169-6320 Ph: (803) 926-7204 |
News Archive
The second annual Dance To Conquer Cancer, Disco Days & Boogie Nights, raising funds for the Princess Margaret Cancer Centre, will take place on March 3, 2013, and will feature fitness guru Richard Simmons and three-time Grammy Award winners, the Pointer Sisters!
Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 Deletion Probe Kit*, a cost-effective fluorescence in situ hybridisation (FISH) kit for the reliable investigation of glial tumours.
Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.
Clinicians often face the challenge of trying to make sense of conflicting reports from parents, teachers, and children about a child's behavioral problems. However, a better understanding of the source and nature of these disagreements may provide important information that could improve treatment and outcomes. A group of articles in the current issue of Journal of Child and Adolescent Psychopharmacology, a peer-reviewed journal published by Mary Ann Liebert, Inc., explores this challenging clinical dilemma.
Pfizer Inc. announced today that the European Commission has approved expanding the use of the company's pneumococcal conjugate vaccine, Prevenar 13(pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), to older children and adolescents aged 6 to 17 years for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by vaccine-type Streptococcus pneumoniae.
› Verified 1 days ago
William Jaimes, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2993 Sunset Blvd, West Columbia, SC 29169 Phone: 803-939-0026 | |
Progressive Physical Therapy West Columbia Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3240 Sunset Blvd, West Columbia, SC 29169 Phone: 803-796-8377 Fax: 803-796-8378 | |
Michael Brett Shealy, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 222 E Medical Ln Ste 100&200, West Columbia, SC 29169 Phone: 803-935-8410 Fax: 803-936-7816 | |
Physical Rehabilitation Group Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 211 Medical Cir, West Columbia, SC 29169 Phone: 803-451-0244 Fax: 803-451-0245 | |
Physical Rehabilitation Group, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 211 Medical Cir, West Columbia, SC 29169 Phone: 803-732-5887 Fax: 803-732-5997 | |
Lauren Michelle Audlin, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2720 Sunset Blvd, West Columbia, SC 29169 Phone: 803-791-2000 | |
Sarah Dominique Meek Springer, Physical Therapist Medicare: Medicare Enrolled Practice Location: 1311 Augusta Rd, West Columbia, SC 29169 Phone: 803-926-7204 |